Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
about
Involvement of Ubiquitin-Editing Protein A20 in Modulating Inflammation in Rat Cochlea Associated with Silver Nanoparticle-Induced CD68 Upregulation and TLR4 ActivationEndotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity.Anti CD163+, Iba1+, and CD68+ Cells in the Adult Human Inner Ear: Normal Distribution of an Unappreciated Class of Macrophages/Microglia and Implications for Inflammatory Otopathology in Humans.Toll-like receptor 4 modulates the cochlear immune response to acoustic injury.Lipopolysaccharide-induced middle ear inflammation disrupts the cochlear intra-strial fluid-blood barrier through down-regulation of tight junction proteins.Survival of auditory hair cells.Asymmetric and unilateral hearing loss in childrenEffect of sepsis and systemic inflammatory response syndrome on neonatal hearing screening outcomes following gentamicin exposureThe Contribution of Immune Infiltrates to Ototoxicity and Cochlear Hair Cell Loss.Two cell populations participate in clearance of damaged hair cells from the sensory epithelia of the inner ear.The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.Drug-induced hearing loss: Infection raises the odds.Temporal bone histopathology of furosemide ototoxicity.Interleukin-10 Attenuates Hypochlorous Acid-Mediated Cytotoxicity to HEI-OC1 Cochlear Cells.Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity.Aminoglycoside-Induced Cochleotoxicity: A Review.Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury.Novel Peptide Vaccine GV1001 Rescues Hearing in Kanamycin/Furosemide-Treated Mice.Immune cells and non-immune cells with immune function in mammalian cochleae.Macrophages in the Human Cochlea: Saviors or Predators—A Study Using Super-Resolution Immunohistochemistry.
P2860
Q27320827-76FF8CD4-FC51-4D45-A669-CA7217358BD4Q27324803-131B7AFB-DC1B-4ACE-AEDF-6754E498DBC4Q30366978-BBA2C2CE-B6AB-476B-9BA6-BEB91850D283Q30367380-CDF865C4-9BAE-4BB6-9632-372C80571F33Q30414927-E93901AC-9A20-40AE-BBED-ECC2E7B94A42Q35811898-87DDC0C7-DF74-430A-A9DC-D57AEA123209Q35811983-44D6C5AD-F957-4F0F-A1F7-63F42C4F3A16Q36122570-E59B774F-F78D-4DAB-980B-D3F377E026A4Q39265394-638995AC-4B85-4AB6-A142-2D0BD474C4C4Q39318748-13AEE227-0378-4E8A-AB67-2C01373E71DCQ40317145-1EA55A03-AE42-41FD-871F-CFF15B43C0C8Q41083330-1B35FEF2-CB65-4866-B398-C5315FEBB551Q45719021-A83757D2-EBBD-4F26-A958-7E753EA9AFCFQ46124483-2C54B69D-10A4-4187-9FB4-B42A4E87390DQ47128203-8DF42F52-42FF-4856-84BF-7A52E0013DB3Q47134842-87A3A06B-CA70-4284-890F-83EA9A8A0F6BQ47346169-82FA7810-E116-4AC9-911A-25C4F868A5D7Q49517786-47900A8A-E73D-405E-AD3A-4BCA46AB2BB8Q50134499-CC297B81-2E2E-4B55-BE2F-051BD19936D4Q50303229-94C50BDA-7A79-4AEE-A414-9CBD58FDCDC5
P2860
Systemic lipopolysaccharide induces cochlear inflammation and exacerbates the synergistic ototoxicity of kanamycin and furosemide.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@ast
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@en
type
label
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@ast
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@en
prefLabel
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@ast
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@en
P2093
P2860
P1433
P1476
Systemic lipopolysaccharide in ...... y of kanamycin and furosemide.
@en
P2093
Keiko Hirose
Kevin K Ohlemiller
Richard M Ransohoff
Song-Zhe Li
P2860
P2888
P304
P356
10.1007/S10162-014-0458-8
P577
2014-05-21T00:00:00Z
P6179
1001859824